Cross Country Healthcare CEO John Martins Departs, Kevin Clark Appointed
Cross Country Healthcare announced that John Martins, the company's president and CEO, has separated from the company and ceased to serve as a member of its board of directors, effective as of December 14. The board appointed Kevin Clark, the company's current chairman, former CEO, and co-founder, to succeed Martins as the company's president and CEO. Clark will continue to serve as the chairman of the board.
Trade with 70% Backtested Accuracy
Analyst Views on CCRN
About CCRN
About the author


Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite rising 0.2%, while the Dow fell slightly by 0.04%. Kroger's stock dropped 6% after reporting mixed quarterly results, despite beating earnings expectations.
Sector Movements: Industrials sector shares increased by 0.7%, while consumer staples stocks fell by 1.2%. Notable gainers included Polyrizon Ltd. (up 92%) and UiPath Inc. (up 22%), while Genesco Inc. saw a significant drop of 30%.
Commodity Prices: Oil prices rose by 1.5% to $59.85, while gold increased by 0.2%. In contrast, silver and copper prices fell by 2% and 0.5%, respectively.
Global Market Trends: European shares were generally higher, with the eurozone's STOXX 600 up 0.45%. Asian markets also closed mostly higher, led by Japan's Nikkei, which gained 2.33%.
U.S. Stock Market Performance: U.S. stocks saw a slight increase, with the Dow Jones up 0.1%, NASDAQ rising 0.01%, and S&P 500 gaining 0.1% on Thursday. Financial shares rose by 0.4%, while health care stocks fell by 0.6%.
Dollar General's Strong Earnings: Dollar General's shares surged over 7% after reporting better-than-expected third-quarter earnings of $1.28 per share and raising its FY25 guidance above estimates.
Notable Stock Movements: Polyrizon Ltd. shares skyrocketed 134% following positive preclinical test results, while Genesco Inc. shares plummeted 28% after disappointing financial results and lowered guidance.
Global Market Trends: European shares rose, with the eurozone's STOXX 600 up 0.5%, and Asian markets mostly closed higher, led by Japan's Nikkei gaining 2.33%. U.S. initial jobless claims decreased by 27,000 to 191,000.

Merger Termination: Cross Country Healthcare (CCRN) has terminated its merger agreement with Aya Holdings due to the inability to extend the deal beyond the December 3, 2025, deadline, resulting in a $20 million termination fee owed by Aya to Cross Country.
Regulatory Delays: The merger faced delays from an FTC Hart-Scott-Rodino review, exacerbated by a historic government shutdown, which pushed the review's end date past the merger's termination date.
Market Impact: Following the announcement of the merger's termination, CCRN shares dropped by 19.6%.
Company Performance: Cross Country Healthcare has missed financial estimates and canceled its earnings call while suspending guidance due to the pending transaction.
Financial Performance Overview: Cross Country Healthcare reported a revenue of $250.1 million for Q3 2025, a 21% decrease year-over-year, with a net loss of $4.8 million and a diluted EPS of $(0.15). Adjusted EBITDA was $6.5 million, reflecting a 37% decline compared to the previous year.
Business Segment Highlights: The Nurse and Allied Staffing segment generated $202 million in revenue, down 24% year-over-year, while Physician Staffing revenue decreased by 4% to $48.1 million. The company experienced a positive cash flow from operations of $20.1 million for the quarter.
Merger Update: Cross Country Healthcare is in the process of merging with Aya Healthcare, with the merger agreement set to close by December 3, 2025, pending regulatory approvals. The merger's timeline has been affected by a government shutdown impacting the FTC's review process.
Operational Efficiency: The company has successfully reduced SG&A expenses and maintained a healthy balance sheet with $99 million in cash and no debt. They have also focused on enhancing their proprietary technology platforms while securing over $400 million in contract value across Managed Service Program clients.

Recognition of Marketing Excellence: Cross Country Healthcare's marketing team has been awarded the title of No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards, highlighting their creativity, innovation, and measurable impact in the healthcare and education sectors.
Innovative Marketing Strategies: The team is recognized for its forward-thinking strategies that blend data, design, and storytelling to effectively connect with clients and communities, driving business growth through demand generation.
Commitment to Continuous Improvement: The marketing organization emphasizes the use of emerging digital and AI technologies to stay ahead of industry changes, showcasing a commitment to innovation and excellence in marketing practices.
Cultural Empowerment and Future Goals: Chief Marketing Officer Gerald Purgay expresses pride in the team's achievements and emphasizes that this recognition serves as motivation to continue challenging conventions and delivering impactful results.







